Stefania Orecchioni

1.7k total citations
42 papers, 1.2k citations indexed

About

Stefania Orecchioni is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stefania Orecchioni has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Stefania Orecchioni's work include Cancer Immunotherapy and Biomarkers (11 papers), Metabolism, Diabetes, and Cancer (9 papers) and Immune Cell Function and Interaction (8 papers). Stefania Orecchioni is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Metabolism, Diabetes, and Cancer (9 papers) and Immune Cell Function and Interaction (8 papers). Stefania Orecchioni collaborates with scholars based in Italy, France and Spain. Stefania Orecchioni's co-authors include Francesco Bertolini, Giovanna Talarico, Patrizia Mancuso, Angelica Calleri, Francesca Reggiani, Valentina Labanca, Adriana Albini, Katiuscia Dallaglio, Douglas M. Noonan and Giuliana Gregato and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Stefania Orecchioni

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefania Orecchioni Italy 22 552 475 275 245 117 42 1.2k
Anna Rita Cantelmo Italy 19 619 1.1× 262 0.6× 246 0.9× 350 1.4× 133 1.1× 27 1.2k
Yunhe Liu China 19 438 0.8× 246 0.5× 167 0.6× 164 0.7× 176 1.5× 51 1.1k
Teruaki Fujishita Japan 16 583 1.1× 408 0.9× 234 0.9× 222 0.9× 126 1.1× 23 1.1k
Dekuang Zhao United States 15 723 1.3× 531 1.1× 169 0.6× 317 1.3× 48 0.4× 29 1.2k
Susana Constantino Rosa Santos Portugal 17 664 1.2× 464 1.0× 224 0.8× 250 1.0× 68 0.6× 41 1.3k
Shujun Lin China 16 822 1.5× 354 0.7× 171 0.6× 179 0.7× 80 0.7× 49 1.4k
Miguel Murillo Spain 14 662 1.2× 379 0.8× 153 0.6× 151 0.6× 73 0.6× 16 1.1k
Md Kamrul Hasan United States 19 611 1.1× 316 0.7× 140 0.5× 163 0.7× 88 0.8× 43 1.1k
Tao Guo China 18 474 0.9× 320 0.7× 164 0.6× 287 1.2× 60 0.5× 49 1.1k
Harald J. Maier Germany 16 613 1.1× 333 0.7× 191 0.7× 280 1.1× 84 0.7× 27 1.1k

Countries citing papers authored by Stefania Orecchioni

Since Specialization
Citations

This map shows the geographic impact of Stefania Orecchioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Orecchioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Orecchioni more than expected).

Fields of papers citing papers by Stefania Orecchioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Orecchioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Orecchioni. The network helps show where Stefania Orecchioni may publish in the future.

Co-authorship network of co-authors of Stefania Orecchioni

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Orecchioni. A scholar is included among the top collaborators of Stefania Orecchioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Orecchioni. Stefania Orecchioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falvo, Paolo, Stefania Orecchioni, Federica Pisati, et al.. (2025). Age-dependent differences in breast tumor microenvironment: challenges and opportunities for efficacy studies in preclinical models. Cell Death and Differentiation. 32(6). 1000–1013. 2 indexed citations
2.
Talarico, Giovanna, Andrea Franceschini, Alessandro Raveane, et al.. (2024). HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients. Discover Oncology. 15(1). 764–764.
3.
Reggiani, Francesca, Giovanna Talarico, Giulia Gobbi, et al.. (2024). BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3. Nature Communications. 15(1). 2567–2567. 9 indexed citations
4.
Orecchioni, Stefania, Paolo Falvo, Giovanna Talarico, et al.. (2023). Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge. Journal of Clinical Medicine. 12(7). 2535–2535. 6 indexed citations
5.
6.
Falvo, Paolo, Nerea Allende-Vega, Michael G. Constantinides, et al.. (2022). The metabolism of cells regulates their sensitivity to NK cells depending on p53 status. Scientific Reports. 12(1). 3234–3234. 24 indexed citations
7.
Falvo, Paolo, Stefania Orecchioni, Saveria Mazzara, et al.. (2022). A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies. Cell Death Discovery. 8(1). 106–106. 22 indexed citations
8.
Falvo, Paolo, Stefania Orecchioni, Alessandro Raveane, et al.. (2020). Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer. Cancer Research. 81(3). 685–697. 47 indexed citations
9.
Falvo, Paolo, et al.. (2020). Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens. Current Medicinal Chemistry. 28(11). 2114–2136. 7 indexed citations
10.
Abdel‐Aziz, Amal Kamal, Paolo D’Amico, Stefania Orecchioni, et al.. (2019). Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside. European Journal of Cancer. 122. 22–41. 14 indexed citations
11.
Orecchioni, Stefania, Giovanna Talarico, Valentina Labanca, et al.. (2018). Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma. British Journal of Cancer. 118(10). 1329–1336. 83 indexed citations
12.
Sánchez‐Martínez, Diego, Nerea Allende-Vega, Stefania Orecchioni, et al.. (2018). Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors. Theranostics. 8(14). 3856–3869. 45 indexed citations
13.
Reggiani, Francesca, Valentina Labanca, Patrizia Mancuso, et al.. (2017). Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression. Cancer Research. 77(18). 5169–5182. 65 indexed citations
14.
15.
Khan, Abrar Ul Haq, Nerea Allende-Vega, Delphine Gitenay, et al.. (2017). The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway. Scientific Reports. 7(1). 10654–10654. 27 indexed citations
16.
Falzacappa, Maria Vittoria Verga, Chiara Ronchini, Mario Faretta, et al.. (2015). The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias. Molecular Cancer Therapeutics. 14(4). 889–898. 25 indexed citations
17.
Allegretti, Matteo, Maria Rosaria Ricciardi, Roberto Licchetta, et al.. (2015). The pan-class I phosphatidyl-inositol-3 kinase inhibitor NVP-BKM120 demonstrates anti-leukemic activity in acute myeloid leukemia. Scientific Reports. 5(1). 18137–18137. 27 indexed citations
18.
Dallaglio, Katiuscia, Antonino Bruno, Anna Rita Cantelmo, et al.. (2014). Paradoxic effects of metformin on endothelial cells and angiogenesis. Carcinogenesis. 35(5). 1055–1066. 123 indexed citations
19.
Bertolini, Francesco, Stefania Orecchioni, Jean‐Yves Petit, & Mikhail G. Kolonin. (2014). Obesity, proinflammatory mediators, adipose tissue progenitors, and breast cancer. Current Opinion in Oncology. 26(6). 545–550. 14 indexed citations
20.
Orecchioni, Stefania, Giuliana Gregato, Inés Martín-Padura, et al.. (2013). Complementary Populations of Human Adipose CD34+ Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer. Cancer Research. 73(19). 5880–5891. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Rita Cantelmo Breakdown of academic impact, for papers by Yunhe Liu Breakdown of academic impact, for papers by Teruaki Fujishita Breakdown of academic impact, for papers by Dekuang Zhao Breakdown of academic impact, for papers by Susana Constantino Rosa Santos Breakdown of academic impact, for papers by Shujun Lin Breakdown of academic impact, for papers by Miguel Murillo Breakdown of academic impact, for papers by Md Kamrul Hasan Breakdown of academic impact, for papers by Tao Guo Breakdown of academic impact, for papers by Harald J. Maier
Rankless by CCL
2026